K-Cl cotransport is a major pathway for the coupled, electroneutral release of potassium and chloride from nonexcitable cells. Potassium chloride cotransporters (KCCs) are members of the cation Cl Ϫ cotransporter gene superfamily. 1,2 To date, 4 mammalian KCCs have been cloned and characterized. 3-9 KCC1 and KCC3 are widely expressed and play important roles in transepithelial transport, cell volume regulation, and regulation of intracellular chloride concentration. 3, [5] [6] [7] [8] [9] [10] Mutation of the KCC3 gene is associated with an autosomal recessive disorder characterized by mental retardation, peripheral neuropathy, and agenesis of the corpus callosum. 11 Mice lacking KCC3 demonstrate peripheral neuropathy and defects in locomotion and sensorimotor gating. 11 KCC3 may also play a role in cell growth regulation. 12 KCC2 is expressed throughout the central nervous system 4, 13, 14 and plays an important role in synaptic transmission. 15, 16 KCC4 is expressed primarily in kidney, heart, lung, and liver. 6 Mice lacking KCC4 exhibit deafness and renal tubular acidosis. 17 Most K-Cl cotransport in the erythrocyte is attributed to KCC1. KCC1 activity is volume-, pH-, and chloride-dependent. 3, 9, 18 The complex mechanisms that regulate KCC activity have been the focus of intensive study. These mechanisms include cell volume, pH, PO 2 , magnesium, calcium, and oxidative changes. 19 Another regulatory pathway of KCC activity is a phosphorylation/ dephosphorylation cycle (for a review, see Merciris and Giraud 20 ) with phosphorylation of the transporter or a regulatory protein decreasing KCC activity and dephosphorylation increasing activity. Erythrocytes from mice deficient in the Src family kinases Fgr and Hck demonstrate elevated KCC activity. 21 The KCC system contributes to the erythrocyte abnormalities in patients with various hemoglobinopathies, particularly sickle cell disease (for a review, see Lauf et al 18 ). K-Cl cotransport activity is activated in sickle cell erythrocytes, 19, 22 contributing to the formation of dense erythrocytes as a consequence of cellular dehydration and potassium loss. 1, 3, 9 Dense erythrocytes play a role in the vasoocclusive manifestations of sickle cell disease. It has been proposed that the KCC1 gene is a candidate modifier gene contributing to the clinical course and response to therapy in sickle cell disease. 2, 23, 24 It is possible that genetic variants of KCC1 exist, particularly in patients with sickle cell disease, with some variants causing increased K-Cl cotransport, cellular dehydration, hemoglobin S polymerization, sickling, and increased disease severity. Because KCC1 is a major contributor to the dehydration of sickle erythrocytes, pharmacologic agents that block this pathway are being examined as therapeutic agents to prevent or ameliorate the complications of sickle cell disease. 25, 26 Although the mechanisms regulating K-Cl cotransport activity are beginning to be revealed, nothing is known about the regulation of KCC1 at the transcriptional level. Understanding the transcriptional regulation of the KCC1 gene may provide additional information on KCC1 activity in wild-type and sickle erythrocytes and may contribute to therapeutic strategies aimed at decreasing KCC activity in sickle erythrocytes. 28 several of the KCC1 isoforms encoded by these cDNAs are predicted to alter KCC1 function. Recent studies have demonstrated that promoter choice influences splice site selection, determining the composition of alternately spliced cDNA isoforms and influencing protein structure and function. [29] [30] [31] Thus, study of the 5Ј ends of KCC1 cDNA isoforms and the identification and characterization of the corresponding promoter(s) is an important priority in the study of KCC1 regulation.
Introduction
K-Cl cotransport is a major pathway for the coupled, electroneutral release of potassium and chloride from nonexcitable cells. Potassium chloride cotransporters (KCCs) are members of the cation Cl Ϫ cotransporter gene superfamily. 1, 2 To date, 4 mammalian KCCs have been cloned and characterized. [3] [4] [5] [6] [7] [8] [9] KCC1 and KCC3 are widely expressed and play important roles in transepithelial transport, cell volume regulation, and regulation of intracellular chloride concentration. 3, [5] [6] [7] [8] [9] [10] Mutation of the KCC3 gene is associated with an autosomal recessive disorder characterized by mental retardation, peripheral neuropathy, and agenesis of the corpus callosum. 11 Mice lacking KCC3 demonstrate peripheral neuropathy and defects in locomotion and sensorimotor gating. 11 KCC3 may also play a role in cell growth regulation. 12 KCC2 is expressed throughout the central nervous system 4, 13, 14 and plays an important role in synaptic transmission. 15, 16 KCC4 is expressed primarily in kidney, heart, lung, and liver. 6 Mice lacking KCC4 exhibit deafness and renal tubular acidosis. 17 Most K-Cl cotransport in the erythrocyte is attributed to KCC1. KCC1 activity is volume-, pH-, and chloride-dependent. 3, 9, 18 The complex mechanisms that regulate KCC activity have been the focus of intensive study. These mechanisms include cell volume, pH, PO 2 , magnesium, calcium, and oxidative changes. 19 Another regulatory pathway of KCC activity is a phosphorylation/ dephosphorylation cycle (for a review, see Merciris and Giraud 20 ) with phosphorylation of the transporter or a regulatory protein decreasing KCC activity and dephosphorylation increasing activity. Erythrocytes from mice deficient in the Src family kinases Fgr and Hck demonstrate elevated KCC activity. 21 The KCC system contributes to the erythrocyte abnormalities in patients with various hemoglobinopathies, particularly sickle cell disease (for a review, see Lauf et al 18 ). K-Cl cotransport activity is activated in sickle cell erythrocytes, 19, 22 contributing to the formation of dense erythrocytes as a consequence of cellular dehydration and potassium loss. 1, 3, 9 Dense erythrocytes play a role in the vasoocclusive manifestations of sickle cell disease. It has been proposed that the KCC1 gene is a candidate modifier gene contributing to the clinical course and response to therapy in sickle cell disease. 2, 23, 24 It is possible that genetic variants of KCC1 exist, particularly in patients with sickle cell disease, with some variants causing increased K-Cl cotransport, cellular dehydration, hemoglobin S polymerization, sickling, and increased disease severity. Because KCC1 is a major contributor to the dehydration of sickle erythrocytes, pharmacologic agents that block this pathway are being examined as therapeutic agents to prevent or ameliorate the complications of sickle cell disease. 25, 26 Although the mechanisms regulating K-Cl cotransport activity are beginning to be revealed, nothing is known about the regulation of KCC1 at the transcriptional level. Understanding the transcriptional regulation of the KCC1 gene may provide additional information on KCC1 activity in wild-type and sickle erythrocytes and may contribute to therapeutic strategies aimed at decreasing KCC activity in sickle erythrocytes. 28 several of the KCC1 isoforms encoded by these cDNAs are predicted to alter KCC1 function. Recent studies have demonstrated that promoter choice influences splice site selection, determining the composition of alternately spliced cDNA isoforms and influencing protein structure and function. [29] [30] [31] Thus, study of the 5Ј ends of KCC1 cDNA isoforms and the identification and characterization of the corresponding promoter(s) is an important priority in the study of KCC1 regulation.
In this report, we describe the identification and characterization of the human KCC1 (hKCCl) gene promoter located immediately 5Ј of the major KCC1 cDNA transcript. Interestingly, the core promoter lacks a TATA box and contains a functional initiator element (InR) and a functional downstream promoter element (DPE), a combination found primarily in Drosophila gene promoters and rarely observed in mammalian gene promoters. Sp1 and AP-2 binding proteins contribute significantly to KCC1 promoter function. This core promoter region is hyperacetylated in erythroid and nonerythroid cells.
Materials and methods

Isolation of the human KCC1 gene
Primary screening of a human genomic DNA BAC library (Genome Systems, St Louis, MO) was performed with a pair of oligonucleotide primers, A and B (Table 1) , as described. 32 These primers flank exon 1 of the hKCC1 gene 33 and amplify a 115-base pair (bp) fragment. Amplificationpositive clones were purified, subcloned, and analyzed by restriction endonuclease digestion, Southern blotting, and partial nucleotide sequencing.
Mapping of the KCC1 transcription initiation site
Total RNA was prepared from human tissues or from the human tissue culture cell lines K562 or HeLa as described. 34 The transcription initiation site of the hKCC1 gene cDNA was determined using a primer extension assay. Oligonucleotide primer C (Table 1) was end-labeled with 32 Padenosine triphosphate ( 32 P-ATP) using T4 polynucleotide kinase (Promega, Madison, WI) followed by ethanol precipitation with template RNA. Templates in these reactions were 25 g K562 or HeLa cell total RNA or 10 g transfer RNA (tRNA). Labeled primer was annealed to template RNA for 30 minutes at 75°C, cooled for 10 minutes at room temperature, then extended for 30 minutes at 43°C in the presence of buffer (50 mM Tris-HCl, pH 8.3, 50 mM KCl, 10 mM MgCl 2, 20 mM dithiothreitol, 1 mM each of 4 dNTPs, and 0.5 mM spermidine), and 20 U avian myoblastosis virus (AMV) reverse transcriptase. Extension products were ethanol precipitated, dissolved in loading buffer, and analyzed on an 8% acrylamide gel adjacent to a sequencing reaction of genomic DNA primed with the same oligonucleotide.
rapid amplification of cDNA ends
Single-stranded oligonucleotide ligation was carried out as described. 35 Nested polymerase chain reaction (PCR) was performed using either human bone marrow or brain cDNA as template with Advantage-2 GC polymerase (Clontech, Palo Alto, CA). The primers used in PCR amplification were D and E (first amplification), then F and G (second amplification) ( Figure 1A ). Amplification products were subcloned and sequenced.
Preparation of nuclear extracts
Nuclear extracts were prepared from K562 and HeLa cells by hypotonic lysis followed by high salt extraction of nuclei, as described by Andrews and Faller. 36 
DNase I footprinting in vitro
Probes for DNase I footprinting were by produced by PCR amplification of plasmids p-369/ϩ18 and p-369/ϩ81 containing hKCC1 genomic fragments (see "Results") with oligonucleotide primers C and H or C and J, respectively (Table 1) . In each reaction, one of the primers had been 5Ј end-labeled with 32 P-ATP using polynucleotide kinase before use in PCR. Reaction mixes contained 75 g K562 cell nuclear extracts, 20 000 cpm labeled probe, and 1 g poly(dI-dC). After digestion with DNase I, samples were electrophoresed in 6% denaturing polyacrylamide gels, and the gels were dried and subjected to autoradiography.
Preparation of promoter-reporter plasmids for transfection assays
A 387-bp fragment corresponding to 5Ј flanking hKCC1 genomic DNA from Ϫ369 to ϩ18 relative to the transcription initiation site was amplified using primers H and I (Table 1) . This fragment was subcloned in both orientations upstream of the firefly luciferase reporter gene in the plasmid pGL2B (Promega), yielding plasmids p-369/ϩ18 and pϩ18/Ϫ368 reverse. Additions, truncations, and mutations of this fragment in the pGL2B plasmid were performed using PCR amplification. Integrity of test plasmids was confirmed by sequencing.
Cell culture
Human tissue culture cell lines K562 (ATCC, CCL 243), HeLa (CCL 2), and HepG2 (primary liver cancer, ATCC HB-8605) were used to study expression of the hKCC1 gene.
Transient transfection analyses
All plasmids tested were purified using Qiagen columns (Qiagen, Chatsworth, CA) or cesium chloride plasmid purification, and at least 2 preparations of each plasmid were tested in triplicate. K562 and HeLa cell transfections were performed as described. 37 All assays were performed in triplicate. Differences in transfection efficiency were determined by cotransfection with the pCMV␤ plasmid. For transactivation assays, HepG2 cells were transfected using 1 g reporter plasmid and varying amounts of AP-2␣, AP-2␤, AP-2␥, and AP-2␦ cDNA expression plasmids (kindly supplied by Drs Trevor Williams (University of Colorado Health Sciences Center, Denver), Helen Hurst (Hammersmith Hospital, London, United Kingdom), Feng Zhao (Mount Sinai School of Medicine, New York, NY), and Bruce Gelb (Mount Sinai School of Medicine)), and the reporter gene activity was assayed. 
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Gel mobility shift assays
Binding reactions were carried out as described. 37 Competitor oligonucleotides were added at molar excesses of 100-fold. Antibodies to AP-2 and Sp1 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Quantitative ChIP assays
Antidiacetylated histone H3 (06-599) and antitetraacetylated histone H4 (06-866) antibodies were obtained from Upstate Biotechnology (Lake Placid, NY). Quantitative chromatin immunoprecipitation (ChIP) analysis was performed as described. 38, 39 After formaldehyde fixation, chromatin was fragmented by sonication 9 times for 10 seconds each. Extracts were precleared with protein G Sepharose, and antibody was added and incubated overnight at 4°C. After elution and extraction, immunoprecipitated DNA was analyzed by quantitative real-time PCR (iCycler; Bio-Rad, Hercules, CA). PCR primers K and L (Table 1 ) amplify a 108-bp fragment corresponding to the core KCC1 promoter. Samples from at least 3 independent immunoprecipitations were analyzed. SYBR green fluorescence in 25 L PCR reactions was determined, and the amount of product was determined relative to a standard curve generated from a titration of input chromatin. Amplification of a single amplification product was confirmed by dissociation curve analysis and agarose gel electrophoresis with ethidium bromide staining. Parallel controls for each experiment included samples of no chromatin, no antibody, nonimmune rabbit immunoglobulin G (IgG), and rabbit nonimmune serum.
Computer analyses
Computer analyses were performed using the BLAST algorithm (National Center for Biotechnology Information, Bethesda, MD). 40 
Results
Cloning of the human KCC1 gene
Screening a human genomic DNA BAC library yielded an approximately 90-kilobase (kb) genomic clone containing all the exons of the hKCC1 gene. 33 An approximately 13.5-kb XbaI fragment containing exons 1 to 3 and the 5Ј flanking KCC1 sequence was isolated from the BAC clone for further characterization. A limited restriction map of this region is shown in Figure 1A .
Mapping the human KCC1 mRNA transcription initiation site
To identify the 5Ј end of the human KCC1 cDNA, primer extension was performed using total RNA from K562 cells. These experiments identified a single transcription initiation site ( Figure S1 ; see the Supplemental Materials link at the top of the online article on the Blood website) and predicted the presence of an additional 22 bp in the mRNA upstream of the sequence from the 5Ј-most EST (IMAGE clone 5174748). This is 52 bp upstream of the 5Ј end previously identified by cDNA cloning ( Figure 1B ). 3 Similar results were obtained using RNA from HeLa cells. The additional 22 bp of upstream 5Ј-untranslated sequence was obtained by 5Ј rapid amplification of cDNA ends (RACE). Sequences obtained by RACE were verified by comparison with corresponding genomic DNA sequences (Figure 2 ). The sequences around the transcription start site, GAA ϩ1 GTGA, do not precisely match the consensus for an InR, YYAϩ1NWYY. 41 However, they do match the most critical sequences of A at ϩ1 and T at ϩ3. 42, 43 More important, they meet the definition for a functional InR-that is, transcription initiates at this location and mutational analyses demonstrate their functional importance (see "Results"). 41 No additional in-frame ATGs were present in the 5Ј-untranslated sequences. Taken together, these data suggest that this sequence is at or very near the 5Ј end of the human KCC1 cDNA.
5-flanking genomic DNA sequence of the hKCC1 gene
The nucleotide sequence of the genomic DNA upstream of the hKCC1 cDNA transcription start site is shown in Figure 3 . 
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Inspection of the sequence reveals a lack of consensus TATA or CCAAT sequences. Consensus sequences for a number of potential DNA-binding proteins, including GATA-1 (2 imperfect sites), GC/CACC-binding related proteins (3 sites), and AP-2 (3 sites) are present in the 5Ј-flanking sequences. GATA motifs bind GATA-1, a zinc finger transcription factor essential for erythroid development. 44, 45 GC or GT/CACC motifs are the binding sites for a number of transcription factors, including ubiquitous proteins such as Sp1 and cell-restricted proteins such as members of the KLF family. 45, 46 AP-2 proteins bind GC-rich sequences and are important in a wide variety of processes, including development, apoptosis, and cell cycle control. 47 When compared with the draft human genomic DNA sequence (NT_010478), we identified an additional 12 bp of sequence, CGGCGGGGACAG, in the 5Ј-untranslated region of the core KCC1 promoter not present in the database. This sequence, which contains consensus-binding sequences for CGCC/CACCC-related proteins, follows a direct repeat in the genomic DNA. We analyzed this region in 24 alleles from unrelated persons and found that all 24 alleles contained the 12 bp. The EST clone that extends through this region (IMAGE clone 5174748) also contains the 12 bp. To begin to identify sequences essential for KCC1 gene expression, plasmids containing 5Ј-flanking sequences linked to a luciferase reporter gene were transiently transfected into K562 and HeLa cells. Plasmids containing KCC1 gene fragments from Ϫ1938, Ϫ720, and Ϫ369 to ϩ81 directed high levels of relative luciferase expression (Figure 3) . A plasmid with the 3Ј end of Ϫ369/ϩ81 deleted at the 3Ј end, from ϩ81 to ϩ18, p-369/ϩ18, directed levels of relative luciferase expression 25.5 Ϯ 5.8-fold over background in K562 cells and 138.1 Ϯ 1.9-fold over background in HeLa cells (Figure 3) . A plasmid with this promoter fragment in reverse orientation, pϩ18/Ϫ386 reverse, directed decreased expression or no expression of the reporter gene. Further deletion of this promoter fragment at the 5Ј end to create p-199/ϩ18 also directed activity in erythroid and nonerythroid cells (Figure 3 ). This promoter fragment contains potential binding sites for GATA-1 and for Sp1 and CACCC-related proteins, a combination shown to be adequate for expression of a minimal promoter in erythroidspecific genes. 45, 47, 48 hKCC1 promoter contains binding sites for Sp1 and AP-2 binding proteins
To identify binding sites for transcription factors within the Ϫ199 to ϩ81 hKCC1 promoter region, DNase I footprinting analysis with nuclear extracts from K562 cells was performed. A single protected region from Ϫ24 to Ϫ9 was observed ( Figure S2 ). This protected region contains consensus-binding sequences for AP-2 (AP-2 site 2; Figures  2-3 ) and Sp1 (Sp1 site 1; Figures 2-3) . The upstream GATA-1 and AP-2 consensus-binding sequences (GATA sites 1-2, AP-2 site 1; Figure 3 ) and the downstream AP-2 and Sp1 consensus-binding sequences (AP-2 site 3, Sp1 sites 2-3), all contained within the sequence of the footprinting probes, were not protected.
AP-2 proteins bind to the hKCC1 gene core promoter in vitro
To determine whether nuclear proteins could bind the footprinted AP-2 site in vitro, double-stranded oligonucleotides containing the corresponding hKCC1 promoter AP-2 sequences or control sequences (Table S1) 49 were prepared and used as probes in gel shift analyses. A single major complex was identified using the KCC1 AP-2 probe that migrated at the same mobility as the control AP-2 probe with both K562 (erythroid) ( Figure 4A ) and HeLa (not shown) extracts. This complex was effectively competed away by Gel mobility shift assays of the AP-2 and Sp1 sites of the hKCC1 gene promoter. Gel mobility shift assays using oligonucleotide probes corresponding to the AP-2 site 2 and Sp1 site 1 consensus-binding sequences of the human KCC1 promoter were performed using K562 nuclear extracts. (A) The probe used in lanes 1 to 5 corresponds to wild-type KCC1 AP-2, the probe used in lanes 6 to 10 corresponds to mutant KCC1 AP-2, and the probe used in lanes 11 to 15 corresponds to a control AP-2. Unlabeled, double-stranded oligonucleotide was added to the reactions as competitor where indicated. (B) The probe used in lanes 1 to 5 corresponds to wild-type KCC1 AP-2, and the probe used in lanes 6 and 7 corresponds to control AP-2. Specific AP-2 antibody was added to the reaction mixtures where indicated. (C) The probe used in lanes 1 to 3 corresponds to wild-type KCC1 Sp1, the probe used in lanes 4 to 6 corresponds to mutant KCC1 Sp1, and the probe used in lanes 7 to 9 corresponds to control Sp1. Specific Sp1 antibody was added to the reaction mixtures where indicated.
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For personal use at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From an excess of unlabeled homologous or control AP-2 oligonucleotide. A mutant KCC1 AP-2 oligonucleotide did not form a DNA-protein complex, nor did it effectively displace wild-type KCC1 AP-2 or control AP-2 oligonucleotides in competition assays ( Figure 4A ). The inclusion of AP-2 ␣, AP-2 ␤, AP-2 ␥, or AP-2 ␦ antisera abolished the DNA binding ( Figure 4B ). These data indicated that AP-2-related proteins bind in vitro to a site of the hKCC1 gene promoter.
Sp1 binds to the hKCC1 gene core promoter in vitro
Similarly, to determine whether nuclear proteins could bind the footprinted Sp1 site in vitro, double-stranded oligonucleotides containing the corresponding hKCC1 promoter Sp1 sequences or control sequences (Table S1) 50 were prepared and used as probes in gel shift analyses. A major complex was identified using the KCC1 Sp1 probe that migrated at the same mobility as the control Sp1 probe with K562 and HeLa extracts ( Figure 4C ). The inclusion of anti-Sp1 antisera supershifted most of the complex. A mutant KCC1 Sp1 oligonucleotide (Table S1 ) did not form a DNA-protein complex. These data indicate that Sp1 binds in vitro to a site of the hKCC1 gene promoter.
AP-2 proteins are major activators of the hKCC1 gene promoter
To further assess the relative importance of AP-2 in promoter function, mutations known to disrupt AP-2 binding (GC-CCGGGGG to GACCGGTGG) 51 were introduced into the AP-2 site protected in DNase I footprinting in the KCC1 promoterreporter gene plasmid, and its effect was assayed in transiently transfected K562 cells. Mutation of this AP-2 site reduced promoter activity by more than half, from 194.1 Ϯ 12.6 (wild-type promoter activity) to 82.7 Ϯ 31.0. Similarly, a mutation known to disrupt Sp1 binding (GGCGGG to GTCGGG) 52 was introduced into the Sp1 site protected in DNase I footprinting in the KCC1 promoter-reporter gene plasmid, and its effect was assayed in transiently transfected K562 cells. Mutation of this Sp1 site reduced promoter activity by one third, to 120.3 Ϯ 10.1.
To determine whether other potential transcription factorbinding sites contributed to promoter function in vitro, individual mutations were introduced into the remaining Sp1, AP-2, and GATA-1 sites shown in Figure 3 . Mutation of the other AP-2 and Sp1 sites did not significantly affect promoter activity (wild-type promoter, 194.1 Ϯ 12.6; AP-2 1, 158.4 Ϯ 26.2; AP-2 3, 189.9 Ϯ 9.9; Sp12, 185.1 Ϯ 18.5; Sp1 3 166.7 Ϯ 18.2). Introduction of a mutation known to disrupt GATA-1 binding and promoter function (GATA to GTTA) 53 into the KCC1 promoter GATA-1 sites did not significantly affect promoter activity in erythroid cells (GATA 1, 186.1 ϩ 39.5; GATA 2, 160.8 ϩ 19.8).
AP-2 transactivates the hKCC1 gene promoter in heterologous cells
Cotransfection of a minimal hKCC1 promoter/luciferase plasmid, p-117/ϩ81 (see below) with AP-2 ␣, AP-2 ␤, AP-2 ␥, or AP-2 ␦ cDNA expression plasmids into HepG2 cells resulted in increasing luciferase activity with increasing amounts of AP-2 plasmid ( Figure 5 ). The ability of AP-2 to transcriptionally activate the hKCC1 promoter in a dose-dependent manner in HepG2 cells, which do not contain AP-2 related proteins, further demonstrates the importance of AP-2 proteins in hKCC1 promoter function.
TATA-less KCC1 gene core promoter contains functional InR and DPE sequences
Transfection assays in K562 and HeLa cells demonstrated that deletion of 63 bp of a 3Ј sequence from the 5Ј flanking DNA in the KCC1 promoter plasmid, p-369/ϩ81 to p-369/ϩ18, significantly decreased reporter gene activity more than 10-fold ( Figure 3 ). This sequence contains consensus-binding sites for AP-2-and CGCC/ CACCC-related proteins. However, mutation of the AP-2 site (site 3, GCCCGGGGC to GCACGGGTC) 51 and the Sp1 sites (sites 2 and 3) 52 had no effect on reporter gene activity. Comparison of the sequence from this region between human and mouse revealed 100% conservation of the protected AP-2 and Sp1 sites. In addition, 43 of 44 nucleotides from position Ϫ6 to ϩ38 (numbering according to human) were homologous. This region encodes the transcription initiation site (the InR) and the sequences GGGCG at position ϩ34 to ϩ 38.
These sequences closely match the consensus-binding sequences and location/spacing for a downstream promoter element, or DPE (KCC1, GGGCGT; DPE, A/G/T C/G A/T C/T A/C/G CT). 54, 55 The presence of an InR and a DPE in a TATA-less promoter, a combination found primarily in Drosophila gene promoters, [55] [56] [57] is beginning to be recognized as an important component of mammalian core promoters. [58] [59] [60] Most DPEs function cooperatively with the InR to direct basal transcription of TATAless promoters. In other cases, they act to recruit transcription factors not generally regarded as part of the basal transcription machinery to regulate transcription ( Figure 6 ). 61 To examine whether a promoter fragment that maintained the DPE but deleted the remainder of downstream 5Ј flanking sequences still directed high-level luciferase expression, the plasmid p-369/ϩ41 was examined in transfection assays. Luciferase expression was reduced by only 20% (Figure S3 ). To test whether the downstream DPE consensus sequences were functional, a mutation predicted to disrupt DPE function (GGGCGTG to CCCACCC) was introduced into the hKCC1 DPE consensus sequence, pϩ369/ ϩ81MutantDPE, and the effect was examined in transfected K562 cells. This mutation decreased luciferase activity by more than two For personal use at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From thirds ( Figure S3 ). In promoters with functional DPEs, the spacing between the InR and the DPE is strictly regulated, usually with the DPE beginning at position ϩ28. However, there is variability, with some DPEs starting between positions ϩ29 and ϩ32, such as the Drosophila engrailed or E75A DPE, located at position ϩ32. 56 In Drosophila promoters, adding 3 bp between the InR and the DPE has been shown to decrease the expression of a linked reporter gene. Introducing a 3-bp spacer between the hKCC1 InR and DPE (AGA inserted between nucleotides [nts] ϩ18 and ϩ19), p-369/ ϩ813bpInsert, decreased luciferase reporter gene activity by more than one third in transfected cells ( Figure S3 ). To test whether a minimal promoter fragment with the downstream promoter sequences still conferred high-level activity to a reporter gene, a core promoter fragment containing the footprinted Sp1 site, the footprinted AP-2 site, and the InR was linked to downstream containing the DPE in a luciferase reporter plasmid, p-117/ϩ81. In transiently transfected K562 cells, this plasmid directed luciferase expression at levels just slightly less than the p-369/ϩ81 bp promoter fragment ( Figure S3 ).
Additional transfection assays were performed in HeLa cells using minimal core promoter fragments in luciferase reporter plasmids to examine the effect of mutations of individual elements on promoter function. A fragment containing single Sp1 and AP-2 sites, the InR and the DPE p-26/ϩ81, directed significant luciferase activity, 180.5 Ϯ 31.7 ( Figure 7A ). Deleting 10 bp, which removed the AP-2 site p-16/ϩ81, reduced activity by one third ( Figure 7A) . Mutation of the Sp1 site, p-16/ϩ81MutantSp1, decreased activity by almost half. Mutation of the InR, the DPE, or both completely abolished promoter function.
To gain additional insight into the function of the KCC1 promoter, the KCC1 InR and DPE elements were substituted into the minimal human TAF II 55 promoter. TAF II 55 is a TATA-less gene that contains a functional initiator and a downstream promoter element beginning at position ϩ29. 62 Two plasmids were prepared. One was a minimal wild-type TAF II 55 promoter, 5Ј-CCGGGTAC-CCCTCCCGCCCCGCGTCGCGACGTAGCACTTCCGTTT TTGCTGGG TAGGCGACCCGGACGGGAGAAGCTTGCC-3Ј, linked to a luciferase reporter gene. The other was a TAF II 55 promoter, with the wild-type InR and DPE replaced by the human KCC1 promoter InR and DPE elements, 5Ј-CCGGGTACCCCTC-CCGCCCCGCGTCGCGACG TAGAAGTGCCGTTTTTGCT-GGG TAGGCGACCCGGGGCGTGAGAAGCTTGCC-3Ј ( Figure  7B ). If the KCC1 InR and DPE elements were nonfunctional, no luciferase activity would have been directed by the TAF II 55/KCC1 hybrid promoter. The TAF II 55/KCC1 hybrid promoter directed levels of luciferase expression approximately 70% of the wild-type TAF II 55 promoter (Figure 7B ), indicating functionality of these elements in a different promoter context.
Chromatin immunoprecipitation analysis of the minimal hKCC1 promoter region
Histone modifications within the minimal hKCC1 gene promoter were examined using a ChIP assay with antidiacetyl histone H3 and antitetraacetyl histone H4 antibodies and PCR primers (K and L) that amplified across a 128-bp core promoter region. Plots of SYBR green fluorescence (relative units) compared with initial input DNA concentrations were linear for K562 (erythroid) and HeLa (nonerythroid) cells, with R 2 ranging from 0.097 to 0.99 (not shown). Representative amplification plots for quantitative analysis of histones H3 and H4 in K562 and HeLa cells are shown in Figure 8A . Dissociation plots from individual amplicons demonstrated single peaks, indicating amplification of a single amplicon. This was verified by ethidium bromide-stained agarose gel electrophoresis.
The core histones H3 and H4 were hyperacetylated in this region in chromatin from K562 cells and HeLa cells ( Figure 8B ). Acetylation of core histones in nucleosomes is a critical chromatin modification. Histone acetylation alters the structure of the nucleosome and higher-order chromatin, increasing the accessibility of nucleosomal DNA, and the acetyl lysine residue may provide a platform for the interaction of proteins involved in transcription.
Discussion
The chloride-dependent, sodium-independent cotransport of potassium and chloride in a 1:1 stoichiometry in the erythrocyte has been studied in great detail. 1, 17 Initially, K-Cl cotransport was viewed as a developmental process in which cotransporter activity promotes the efflux of potassium followed by water from high-potassium erythroid precursors and reticulocytes, decreasing cell volume with cellular maturation. This cotransport activity, which is negligible in mature erythrocytes, was increased in certain hemoglobinopathies, particularly sickle cell disease, contributing to cellular dehydration. In the erythrocyte, K-Cl cotransport activity has been attributed to KCC1 with possibly some contribution from KCC3. 63 Northern blot analyses with KCC1-specific probes demonstrated that the RNA is ubiquitously distributed, suggesting function for KCC1 outside the erythrocyte. 3, 9 Beyond its possible housekeeping function, the role of KCC1 in volume regulation and transepithelial transport in renal cells, in vascular reactivity, in cervical cancer, and in the genesis of arrhythmias after myocardial ischemia are some of the functions under investigation. 2, [64] [65] [66] [67] [68] The identification of a TATA-less KCC1 gene promoter containing functional InR and DPE elements is an unusual finding in a mammalian promoter. In Drosophila, approximately half of all core promoters contain a TATA box and an InR at the transcription initiation site. The other half lack a TATA box and contain an InR and a DPE located approximately 30 bp 3Ј of the transcription initiation site. 54, 59 The TATA box, the InR, and the DPE are capable of recognizing the TFIID complex. In mammalian genes, core promoter structure is more complex than Drosophila. Fewer promoters contain TATA boxes, 69 fewer promoters have TATA boxes and InR, DPEs have been rarely described, 62, 70, 71 and many mammalian promoters lack all 3 core promoter elements. 60 It is likely that the variable occurrence of TATA, InR, and DPE use makes an important contribution to combinatorial gene regulation, 60,72-76 with differences arising not from mechanisms of transcription initiation from different core promoter structures but from interactions with transcription factors not considered part of the general transcription machinery. 31, 60, 61 Similar to the KCC1 promoter, several TATA-less promoters are regulated by Sp1 and AP-2 proteins. 69, 76, 77 One of these, the human TAF II 55 gene, is one of the few mammalian genes described with function InR and DPE elements. 69 It will be interesting to determine whether this combination-that is, a TATA-less core promoter with functional InR and DPEs regulated by Sp1 and AP-2-emerges as a common mammalian core promoter arrangement. For personal use at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From
